Working to identify the root cause of multiple neurologic, psychiatric, and behavioral disorders.
Moleculera Biosciences Achieves CAP Accreditation, Demonstrating Diagnostic Testing Excellence
Read
Moleculera Biosciences to advance first-of-its-kind biomarker panel for Alzheimer’s through alliance with Lunai Bioworks
Moleculera Biosciences Appoints Dr. Michael Rossbach to its Advisory Board
Antineuronal antibody testing that can assist clinicians in identifying whether neuropsychiatric symptoms may be due to an underlying autoimmune response.
Infections can induce an autoimmune attack on the brain, leading to the onset of neurologic and/or psychiatric symptoms.
High complexity metabolic testing, based on over two decades of research and utilized by more than 2,500 clinicians worldwide.
An abnormal immune response, often triggered by an infection, can cause various neurologic and psychiatric symptoms.
This content is password-protected. To view it, please enter the password below.
Password:
